TORONTO, Oct. 16 /CNW/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a
developer of real-time medical imaging systems and image guided therapies for
the operating room, today announced that it will launch the PINPOINT(TM)
endoscopic imaging system at the Annual Meeting of American College of Chest
Physicians (ACCP), CHEST 2007, to be held in Chicago, IL, October 22nd - 25th,
2007. PINPOINT is based upon the endoscopic technology Novadaq acquired from
Xillix Technologies Inc., and is designed to not only perform white light
bronchoscopy, but also the more clinically relevant imaging commonly referred
to as autofluorescence and narrow band imaging. Many studies have shown
autofluorescence to be more effective in the detection and localization of
central airway cancers than conventional white light bronchoscopy. The ACCP
Evidence Based Practice Guidelines now recommend the use of autofluorescence
bronchoscopy for the localization of certain lung cancers, for guiding
endoluminal therapies, and as a surveillance tool in patients with
pre-invasive disease.
